Mode
Text Size
Log in / Sign up
N/A N=33

Remote Assessment of Physical Function

Cancer Survivors

Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcome: Primary: Validation - 30-second Chair Stand Test — 0.33 chair stands

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Remote Assessment of Physical Function with Direct Observation (Other); Remote Assessment of Physical Function (Other)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
University of New Mexico
Primary completion
Nov 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Validation - 30-second Chair Stand Test
0.33
PRIMARY
Validation - Timed Up & Go Test
1.27
SECONDARY
Reliability - Percentage of Participants Who Successfully Completed the Revised Protocol.
9

Summary

The primary objective is to evaluate the validity and reliability of using videoconferencing to assess physical performance tests self-administered by older cancer survivors in their own homes. This remote assessment will be compared to the traditional face-to-face (i.e., in-person) assessment and to accelerometer data.

Eligibility Criteria

Inclusion Criteria

  • Residence in New Mexico
  • Previous diagnosis of cancer, completed primary treatment (surgery, radiation, chemotherapy), and not currently being treated for a recurrence.
  • Mild-to-moderate physical functional impairment (≥2 functions limited a lot or limited a little on the Short Form 36-item Physical Function Subscale)
  • Able to speak, read, & understand English
  • Participating in less than 120 minutes per week of moderate-to-vigorous intensity physical activity
  • Living independently and capable of walking 3 blocks without stopping to rest.
  • Availability of a family member or friend to be present (for safety) during remote assessment of performance tests (Phases III and IV only)
  • No severe impairments or pre-existing medical limitations for engaging in daily light-intensity physical activity (e.g., severe orthopedic conditions, pending hip/knee replacement, chronic vertigo, dementia)
  • No severe hearing or vision deficits that would inhibit communication with the research team via videoconferencing and tablet use.
  • Willing to use a tablet computer and videoconferencing software to communicate with a study team member during the assessment.
  • Enough space (14 feet by 3 feet) to safely conduct the physical function tests.
  • Not at high risk for falls
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04339959). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search